HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhou Zhou Selected Research

C 684

10/2021Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene.
1/2020Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhou Zhou Research Topics

Disease

55Neoplasms (Cancer)
12/2022 - 11/2011
41Inflammation (Inflammations)
07/2022 - 01/2012
17Neoplasm Metastasis (Metastasis)
03/2022 - 05/2012
16Breast Neoplasms (Breast Cancer)
01/2022 - 05/2012
15Infections
10/2022 - 11/2011
11Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 07/2009
11Thrombosis (Thrombus)
01/2020 - 07/2009
9Atherosclerosis
06/2017 - 01/2012
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2011
8Carcinoma (Carcinomatosis)
11/2021 - 11/2010
8Fibrosis (Cirrhosis)
10/2021 - 01/2012
8Hypoxia (Hypoxemia)
01/2020 - 02/2005
7Obesity
07/2022 - 08/2009
7Insulin Resistance
07/2022 - 08/2009
7Cataract (Cataracts)
01/2020 - 04/2010
7Body Weight (Weight, Body)
01/2019 - 04/2013
6Heart Failure
09/2022 - 10/2015
6Melanoma (Melanoma, Malignant)
01/2022 - 01/2018
6Carcinogenesis
01/2022 - 05/2012
6Fatty Liver
05/2019 - 10/2015
6Alzheimer Disease (Alzheimer's Disease)
01/2014 - 07/2009
5Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2009
4Coronary Disease (Coronary Heart Disease)
02/2022 - 06/2007
4Necrosis
01/2022 - 02/2012
4Craniocerebral Trauma (Head Injury)
10/2021 - 07/2016
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2020 - 01/2017
4Liver Diseases (Liver Disease)
01/2020 - 01/2016
4Binge Drinking
01/2019 - 07/2017
4Neuroblastoma
10/2016 - 08/2010
4Rheumatoid Arthritis
01/2014 - 06/2012
4Thrombotic Thrombocytopenic Purpura
01/2013 - 07/2009
3Cognitive Dysfunction
12/2022 - 03/2008
3Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 09/2017
3Thoracic Aortic Aneurysm
02/2022 - 12/2021
3Pneumonia (Pneumonitis)
01/2022 - 01/2016
3Brain Injuries (Brain Injury)
01/2022 - 01/2017
3Nervous System Diseases (Neurological Disorders)
05/2021 - 01/2010
3Hepatocellular Carcinoma (Hepatoma)
03/2021 - 05/2016
3Adenocarcinoma
01/2020 - 05/2012
3Non-alcoholic Fatty Liver Disease
01/2020 - 11/2015
3Colitis
01/2020 - 01/2012
3Alcoholic Fatty Liver
05/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2010
16Pharmaceutical PreparationsIBA
01/2021 - 12/2011
13hydroxypropyl methacrylateIBA
10/2020 - 02/2012
11Glucose (Dextrose)FDA LinkGeneric
07/2022 - 08/2009
11Ethanol (Ethyl Alcohol)IBA
01/2020 - 10/2015
10CadmiumIBA
02/2022 - 01/2016
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
9CytokinesIBA
01/2021 - 07/2012
8ElementsIBA
01/2022 - 07/2016
8Messenger RNA (mRNA)IBA
01/2022 - 02/2005
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 11/2011
8LipidsIBA
01/2021 - 08/2009
7Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 06/2014
7EnzymesIBA
01/2022 - 11/2010
7von Willebrand FactorIBA
01/2016 - 06/2009
6Therapeutic UsesIBA
07/2022 - 12/2014
6Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2012
6CollagenIBA
01/2022 - 04/2011
6Peptides (Polypeptides)IBA
01/2021 - 02/2012
6MelatoninIBA
10/2019 - 04/2013
5RNA (Ribonucleic Acid)IBA
06/2022 - 03/2018
5Interleukin-6 (Interleukin 6)IBA
02/2022 - 06/2012
5Small Interfering RNA (siRNA)IBA
03/2021 - 11/2011
5methacrylamideIBA
10/2020 - 03/2012
5Hormones (Hormone)IBA
06/2020 - 02/2015
5NickelIBA
01/2020 - 05/2011
5MicroRNAs (MicroRNA)IBA
01/2019 - 01/2014
5MicellesIBA
09/2017 - 08/2014
4Mitochondrial DNA (mtDNA)IBA
02/2022 - 01/2010
4LigandsIBA
01/2022 - 01/2012
4Biological ProductsIBA
01/2022 - 03/2018
4Caspase 3 (Caspase-3)IBA
01/2022 - 02/2005
4LipopolysaccharidesIBA
01/2022 - 11/2016
4Membrane Proteins (Integral Membrane Proteins)IBA
04/2021 - 01/2010
4Phosphotransferases (Kinase)IBA
05/2020 - 11/2011
4Sirtuin 1IBA
01/2020 - 07/2015
4Glycoproteins (Glycoprotein)IBA
12/2016 - 11/2012
3AcidsIBA
09/2022 - 12/2019
3Insulin (Novolin)FDA Link
02/2022 - 01/2021
3Adenosine Triphosphate (ATP)IBA
02/2022 - 04/2016
31,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
02/2022 - 12/2021
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2021 - 06/2017
3PolymersIBA
10/2021 - 01/2016
3Interleukin-17 (Interleukin 17)IBA
10/2021 - 01/2012
3CarcinogensIBA
08/2021 - 05/2016
3MetalsIBA
01/2021 - 10/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2010
3Toll-Like Receptor 4IBA
01/2021 - 05/2013
3N-(2-hydroxypropyl)methacrylamideIBA
01/2021 - 10/2014
3Triglycerides (Triacylglycerol)IBA
01/2021 - 08/2009
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 12/2011
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2019 - 02/2012
3Indicators and Reagents (Reagents)IBA
03/2018 - 09/2009
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 11/2015
3InflammasomesIBA
04/2017 - 01/2016

Therapy/Procedure

44Therapeutics
06/2022 - 12/2011
5Drug Therapy (Chemotherapy)
01/2022 - 09/2017
3Intraperitoneal Injections
07/2022 - 10/2018